Endocannabinoids and Immunity.

Area of Science:

• Immunology
• Lipid Signaling
• Inflammation Research

Background:

• Recent research has significantly advanced our understanding of endocannabinoids (eCBs).
• These bioactive lipids are produced by immune cells and modulate immune functions via specific receptors and enzymes.
• eCBs play a crucial role in regulating inflammatory processes.

Purpose of the Study:

• To review the immunomodulatory and anti-inflammatory properties of major endocannabinoids (eCBs).
• To discuss the effects of eCBs across various innate and adaptive immunity compartments.
• To explore the potential of eCBs as master regulators of the innate-adaptive immune axis and as immunoresolvents.

Main Methods:

• Literature review of studies on endocannabinoids and immunity over the past decade.
• Analysis of research on the synthesis, degradation, and receptor interactions of eCBs.
• Synthesis of findings on eCB effects in different immune system components.

Main Results:

• Endocannabinoids (eCBs) exhibit diverse immunomodulatory effects on both innate and adaptive immunity.
• These bioactive lipids act as secondary messengers, fine-tuning numerous immune responses.
• eCBs influence immune cell function and inflammatory pathways.

Conclusions:

• Endocannabinoids (eCBs) are potent regulators of immune responses.
• They play a critical role in bridging innate and adaptive immunity.
• eCBs show promise as therapeutic agents for inflammatory conditions due to their immunoresolvent properties.